According to Sigilon Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ13.11 Million. In 2022 the company made a revenue of ยฃ10.69 Million an increase over the revenue in the year 2021 that were of ยฃ7.11 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.